Evidence map›Paper›PMID 24733503›Full record

ArticleJournal of bioenergetics and biomembranes2014

MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo.

Taylor A Mattox, Martin E Young, Carrie E Rubel, Carolyn Spaniel, Jessica E Rodríguez, Trisha J Grevengoed, Mathias Gautel, Zhelong Xu, Ethan J Anderson, Monte S Willis

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Ubiquitin Proteasome System Role in Diabetes-Induced Cardiomyopathy.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Emerging Strategies Targeting Catabolic Muscle Stress Relief.International journal of molecular sciences · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Taylor A MattoxDepartment of Pharmacology, East Carolina University, Greenville, NC, USA.
Martin E Young
Carrie E Rubel
Carolyn Spaniel
Jessica E Rodríguez
Trisha J Grevengoed
Mathias Gautel
Zhelong Xu
Ethan J Anderson
Monte S Willis
University of North Carolina at Chapel Hill · USEast Carolina University · USKing's College London · GBTianjin Medical University · CNUniversity of Alabama at Birmingham · US

Funding

Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Myocyte specific regulation of metabolism and the response to biomechanical forceR01HL104129 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WILLIS, MONTE S · 2010 to 2018
$3.3M
British Heart Foundation PG/11/127/29322Medical Research Council G0600251Medical Research Council MR/J010456/1NHLBI NIH HHS R01 HL104129NHLBI NIH HHS R01HL104129NHLBI NIH HHS T32 HL069768
6 · The paper itself

Abstract

MuRF1 is a previously reported ubiquitin-ligase found in striated muscle that targets troponin I and myosin heavy chain for degradation. While MuRF1 has been reported to interact with mitochondrial substrates in yeast two-hybrid studies, no studies have identified MuRF1's role in regulating mitochondrial function to date. In the present study, we measured cardiac mitochondrial function from isolated permeabilized muscle fibers in previously phenotyped MuRF1 transgenic and MuRF1-/- mouse models to determine the role of MuRF1 in intermediate energy metabolism and ROS production. We identified a significant decrease in reactive oxygen species production in cardiac muscle fibers from MuRF1 transgenic mice with increased α-MHC driven MuRF1 expression. Increased MuRF1 expression in ex vivo and in vitro experiments revealed no alterations in the respiratory chain complex I and II function. Working perfusion experiments on MuRF1 transgenic hearts demonstrated significant changes in glucose oxidation. However, total oxygen consumption was decreased [corrected]. This data provides evidence for MuRF1 as a novel regulator of cardiac ROS, offering another mechanism by which increased MuRF1 expression may be cardioprotective in ischemia reperfusion injury, in addition to its inhibition of apoptosis via proteasome-mediate degradation of c-Jun. The lack of mitochondrial function phenotype identified in MuRF1-/- hearts may be due to the overlapping interactions of MuRF1 and MuRF2 with energy regulating proteins found by yeast two-hybrid studies reported here, implying a duplicity in MuRF1 and MuRF2's regulation of mitochondrial function.

Indexed as

AnimalsCells, CulturedCitric Acid CycleEnergy MetabolismEnzyme ActivationMiceMice, KnockoutMitochondria, HeartMuscle ProteinsOxygenOxygen ConsumptionReactive Oxygen SpeciesTripartite Motif ProteinsUbiquitin-Protein LigasesMuscle ProteinsOxygenReactive Oxygen SpeciesTrim63 protein, mouseTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID24733503
PMCPMC4047114
OpenAlexW2101129171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.